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Modification of the cellular immune response by sensitization with adjuvants con- 
taining tubercle bacilli has been carefully studied in whole animals of several species 
(1-5). Guinea pigs immunized with a  foreign protein in Freund's complete adjuvant 
(CFA)  1 develop persistent delayed hypersensitivity with an  erythematous skin test 
response  that  is  delayed in  onset,  indurated,  and  characterized histologically by a 
prominent  mononuclear  infiltrate  (1,  6).  By  contrast,  animals  immunized  with  a 
protein in  Freund's incomplete adjuvant  (IFA) without  tubercle bacilli exhibit an 
erythematous reaction that is delayed in onset, but that lacks significant induration 
and that can only be elicited at early intervals after sensitization (7-10). Raffel and 
Newel  (7)  differentiated  this  "Jones-Mote"  reaction  from  that  of  classic delayed 
hypersensitivity, but many have considered Jones-Mote hypersensitivity only a weak 
expression of the delayed response (see reference 11 for review). 
Recently, Dvorak et al. (10)  have demonstrated that Jones-Mote lesions exhibit a 
distinct histology,  featuring  substantial  accumulations  of  basophilie leukocytes  in 
addition to  mononuclear cells, and  have  suggested that cutaneous  basophil hyper- 
sensitivity (CBH)  would provide a  more  descriptive name  for  this reaction.  CBH 
resembles delayed hypersensitivity in  that  both  can  be  transferred passively with 
sensitized lymph node cells, but not with serum  2 (12), both require an immunogenic 
protein or protein conjugate for elicitation (9), and both are inhibited by anti-lympho- 
cyte serum (9). 
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In the present study we compare the proliferative response of cells isolated 
from guinea pigs exhibiting either  CBH or delayed hypersensitivity. L)anph 
node cells from animals primed for CBH with human serum albumin (HSA) 
in IFA exhibited striking stimulation of thymidine incorporation on expsoure 
to specific antigen. The in vitro response, like the associated skin reaction, was 
transient and could be  elicited only at  early intervals after  sensitization. A 
persistent proliferative response occurring at progressively lower antigen con- 
centration  (13)  was  attained  after  immunization with  the  same  amount of 
HSA  ill  emulsions containing tubercle  bacilli.  In  addition,  antigen-specific 
inhibition of  macrophage  migration  was  demonstrated  only  with  exudates 
from  animals sensitized with  complete  adjuvant. In an  attempt  to  explain 
these differences in response,  tissue concentrations of  antigen were measured 
following  immunization with  HSA  emulsified  in  complete  and  incomplete 
adjuvants. 
Materials and Methods 
Antigens and Adjuvants.--Solutions of HSA, crystallized, old tuberculin  (OT), and pre- 
servative-free purified protein derivative of tuberculin  (PPD) 3 were prepared as previously 
described (13). 
CFA contained 50 parts saline, 42.5 parts Bayol 55, 7.5 parts Aflacel A,  4 and sufficient 
heat-killed tubercle bacilli to provide a final concentration of 3 mg/ml. In some experiments 
the concentration of tubercle bacilli was reduced 10-fold to 300 #g/ml (CFA 1:10). IFA was 
prepared from the same formula, omitting tubercle bacilli. 
Immunizations, Skin Tests, and Antibody Assays.--Male Hartley guinea pigs (450-500 g) 
were sensitized with 100 Jzg HSA emulsified in IFA, CFA, or CFA  1:10, divided equally 
among the four footpads. Control groups received adjuvant lacking HSA. Tolerance was in- 
duced with 5 mg HSA in 1 ml saline injected intravenously immediately before sensitization. 
Skin tests were performed with 10 or 50/~g HSA and with 1:100 or 1  : 500 OT. Reactions 
were scored and examined histologically as previously described (10). Anti-HSA titers were 
determined by tanned red cell hemagglutination and hemolysis, and by passive cutaneous 
anaphylaxis (PCA) (13). 
Lymphocyte-Culture and Macrophage-Migration Studies.--Lymphocyte cultures were pre- 
pared and data analyzed by the methods described in the preceding paper (13). 
For studies of macrophage migration, the technique of David et al.  (14) was employed. 
Exudates were obtained from sensitized or nonsensitized Hartley guinea pigs 4 days after 
intraperitoneal injection of 20 ml of sterile Bayol 55, washing the peritoneum with 150 ml of 
Hanks' balanced salt solution. Cells were concentrated by centrifugation at 1000 rpm for 10 
min at 4°C, washed twice with Hanks' solution, and resuspended to 10% by volume in Eagle's 
minimal essential medium (MEM) supplemented with 15% fresh normal guinea pig serum 
(NGPS). Log dilutions of HSA were prepared in saline supplemented with 1% NGPS. Ap- 
propriate amounts of antigen or diluent were added to samples of the cell suspension. Capillary 
tubes were filled from these samples, sealed, and centrifuged at 800 rpm for 5 rain. Capillaries 
were cut at the cell fluid interface, and secured in a Mackaness chamber with a small amount 
of silicone grease. Chambers were sealed with paraffin and filled with MEM containing 15% 
NGPS,  100 units/ml of penicillin, 100/zg/ml  of streptomycin, and appropriate  amounts of 
3  The generous gift of Parke, Davis & Co., Inc., Detroit, Mich. 
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antigen or diluent. Two capillaries were positioned in each chamber and four chambers pre- 
pared for each concentration of antigen (0, 10, 100, and 1000 tzg/ml HSA). Following incuba- 
tion for 24 hr at 37°C in 5% CO2-95% air, areas of migration were projected, traced, and 
measured by planimetry. Cytotoxic indices were calculated for cells from each animal: 
average area of migration with antigen 
cytotoxic index  = 
average area of migration without antigen 
Average cytotoxic indices were calculated for each group of four to six animals and the signifi- 
cance of differences between groups was evaluated with the t test. 
Antigen Carry-Over.--To estimate  the  amount of  antigen  transferred  to  cultures  witb 
lymph node cells from sensitized animals, groups of five guinea pigs were immunized with 100 
/zg 1~I trace-labeled HSA (specific activity 100 #Ci/mg) in CFA or IFA (13). Animals were 
placed on potassium iodide several days before injection. 1 wk after sensitization, draining 
lymph nodes were harvested,  processed for tissue culture,  and counted in a gamma spec- 
trometer. Estimated increments of 4 X  10  -4 and 8 X  10  -4 #g HSA/ml were contributed to 
each culture by 1 X  107 cells sensitized with HSA in IFA and CFA respectively. As these 
values represent  less than  1%  of the minimal antigen  concentration  employed to induce 
lymphocyte stimulation,  the  amount  of antigen carried  over would not have affected our 
experimental results. 
Release and Systemic Distribution of Antigen in Different A djuvants.--In order to determine 
the rate of release of HSA from adjuvant depots and the fate of disseminated antigen, groups 
of five guinea pigs treated with potassium iodide were sensitized with 100/~g 125I HSA (4.1 
#Ci)  incorporated in CFA, CFA  1:10,  or IFA. At various intervals  after  immunization, 
animals were exsanguinated and different tissues excised and counted in a Packard autogamma 
spectrometer (Packard Instrument Co., Inc., Downer's Grove, Ill.) Four feet, spleen, thymus, 
a single  femur, plasma, and the draining lymph nodes were removed from each animal. Lymph 
nodes were weighed to permit calculation of specific activity. 
RESULTS 
Immunologic  Response  to  lISA  Administered  with  Different  Adjuvants.- 
Animals immunized with 100/~g HSA in IFA exhibited erythematous, nonin- 
durated, delayed onset skin reactions characteristic of CBH at 1 and 2 wk after 
sensitization (Table I). At 4 and 6 wk, reactions achieved maximal intensity in 
a  few hours,  but persisted  at  24 hr  as  slightly indurated lesions of  one-half 
the diameter observed in animals skin tested at earlier intervals. These "late" 
reactions differ from  CBH histologically and may be mediated by antibody 
(10).  Immunization with  100/~g HSA in either CFA or CFA 1:10 produced 
characteristically indurated skin-test reactions  of  comparable  diameter  at  1 
wk. Reactions were more indurated, though no larger, at 6 wk. 
Hemagglutinating antibodies were present in high titer at 1 and 6 wk in all 
groups  sensitized with  100  #g  HSA.  However,  animals sensitized with  IFA 
produced significant titers of PCA  ('}'1) but not of hemolytic (3'2 and macro- 
globulin) antibody at 1 wk. With CFA, low titers of hemolytic antibody were 
observed in the absence of PCA activity. With CFA  1:10, low titers of both 
types of antibody were produced at 1 wk. By 6 wk, significant titers of PCA 
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Effect of Sensitization with Different Adjuvants on Antigen-Induced Thymidine 
Uptake.--Groups of 6-14 guinea pigs were immunized with 100/zg HSA in IFA, 
CFA,  or CFA  1:10,  and  equivalent groups were sensitized with  the various 
adjuvants lacking HSA. Cultures of draining lymph node cells were prepared 
at 1 and 6 wk and incorporation of 3H-thymidine was measured as a function 
of HSA concentration in vitro. 
TABLE  I 
Immunologic  Response at Different Intervals  in Animals Sensitized  with 100 3zg HSA 
in Various A djuvants 
Delayed skin reactions*  Antibody Titers~t 
6 
.R<  .=m  TCA  PCA  TCH 
Adjuvant  ~ 
-~  "~'~ o=  50 ~g HSA  10 ~g HSA  .=~  ~  ¢~ 
wk 
1 
mg 
CFA  23  ++  (6/6)  16  +  (9/10)  640  (8/8)  8  0  0  20  (6/8) 
CFA 1:10  23  ++  (6/6)  15  +  (5/6)  1280  (6/6)  2  1  3  tJ  20  (5/6) 
IFA  170  (8/8)  120  (11/11)  320  (14/14)  3  3  7  0  0  (0/14) 
IFA  5  50  (4/6)  20  (3/6)  40  (3/5)  5  0  0  0  0  (0/5) 
IFA  200  (6/6)  9 o  (6/6)  640  (6/6)  0  0  1  5  80  (6/6) 
IFA  5  20 o  (5/6)  12 o  (5/6)  80  (5/6)  2  1  3  0  0  (0/6) 
IFA  12  +  (6/6)  9  +  (5/6)  640  (11/11)  0  0  0  11  320  (U/ll) 
IFA  5  22  +  (6/6)  12 o  (6/6)  640  (11/11)  0  0  6  5  10  (3/11) 
CFA  22  +++  (ll/U)  13  ++  (11/11)  640  (11/11)  1  1  3  6  640  (11/11) 
CFA 1:10  21  +++  (6/6)  12  ++  (6/6)  1280  (6/6)  0  0  2  4  1280 (6/6) 
IFA  11  +  (7/9)  7  o  (7/9)  640  (11/11)  0  0  9  2  320  (11/11) 
* Skin reactions at 24 hr, expressed as average diameter of erythema  (mm) and mean degree of induration 
(0-++++).  Numbers in parentheses are fractions of animals giving detectable responses. 
:~ TCA, tanned cell hemagglutination; TCH, tanned cell hemolysis. TCA and TCH expressed as reciprocal of 
titer.  0 is negative at serum dilution of 1: 5. Numbers in parentheses  are tractions of animals with detectable 
titers. PCA is expressed as the fraction of animals responding at different serum dilutions. 
At  1 wk,  cells from animals  immunized  with  HSA  in  IFA  showed  6-fold 
stimulation relative to controls at an optimal antigen concentration of 10 mg/ml 
(Fig.  1). Statistically significant stimulation was achieved with as little as 10 
#g/ml.  By contrast,  cells from animals  sensitized with HSA in  CFA gave a 
weak,  irregular response at 1 wk,  showing significant stimulation only at an 
antigen concentration of 1 mg/ml. Immunization with HSA in CFA  1:10 led 
to an intermediate response with optimal stimulation at 1 mg/ml,  and a  sig- 
nificantly enhanced incorporation at 10/~g/ml. 
At 6 wk,  the pattern  of response had reversed (Fig. 2).  Cells from animals 
sensitized with  HSA  in IFA  failed to respond  at any antigen concentration 
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significant  stimulation  with  as little  as 0.1  ~g HSA/ml.  An optimal stimula- 
tory index of 5, observed at 1 or 10 mg HSA/ml, was comparable to the maxi- 
mal index achieved with HSA in IFA at 1 wk. 
Production  of  Partial  Tolerance to  CBH.--A  single  intravenous  injection 
of 5 mg HSA at the time of sensitization with 100/~g HSA in IFA substantially 
reduced but did not eliminate cutaneous reactivity at 1 wk (Table I). By 2 wk, 
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Fro. 1.  Stimulation  of  thymidine incorporation by  draining  lymph node cells  cultured 
with different concentrations of antigen at 1 wk after sensitization with 100 ~zg HSA incorpo- 
rated in IFA, CFA, or CFA 1:10. Each point here and in Figs. 2 and 3 represents the mean 
stimulatory  index determined from 5-12 guinea pigs sensitized with HSA in adjuvant,  and 
from a like number of animals sensitized with each of the adjuvants alone (see Materials and 
Methods).  O  O, IFA; [~... n, CFA; and /k---A, CFA 1:10. A closed symbol desig- 
nates  a statistically  significant antigen-lnduced  stimulation  (P <  0.05) as compared with 
adjuvant controls. 
skin  reactions  were  comparable  to,  and  at  4  wk  actually  exceeded  reactions 
observed  in  sensitized  controls.  Hemagglutination  and  PCA  titers  were  only 
transiently  depressed  but  hemolytic  antibody  was  effectively reduced  for  at 
least 4 wk. 
When cells from partially tolerant animals were cultured at 1 wk after sensi- 
tization (Fig. 3), significant stimulation was obtained only at the highest anti- 
gen concentration studied (10 mg/ml). Even at this antigen level, the response 
of tolerant cells was significantly reduced relative to sensitized controls. 
InhibiEon  of Macrophage Migration.--Guinea  pigs  were  immunized  with 
100/~g HSA in either IFA or CFA and peritoneal exudates obtained at 1 and R.  (2.  BAST, JR.,  B.  A.  SIMPSON, A.-~D It.  :F.  DVORAK  207 
3 wk. Macrophage migration from capillary tubes was measured in the absence 
of  antigen  and  in  concentrations  of  HSA  ranging  from  10  to  1000  /~g/ml. 
Cytotoxic indices significantly different from those obtained with nonsensitized 
control exudates were observed only with cells from animals immunized with 
HSA in CFA and only at 3 wk after sensitization  (Table II). At this interval 
10/zg/ml HSA inhibited migration by 50 %, and progressively  greater inhibition 
was  obtained  with  higher  antigen  concentrations.  Peritoneal  exudate  cells 
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FIO. 2.  Stimulation of thymidine incorporation by draining lymph node cells cultured with 
different concentrations of antigen at 6 wk after sensitization with 100/zg HSA incorporated 
in IFA, CFA, or CFA 1  : 10. Symbols same as for Fig. 1. 
from animals  immunized with  HSA  in  IFA were not  inhibited  by even  the 
highest antigen concentration at either interval studied. 
Release and Systemic  Distribution  of Antigen  in Different Adjuvants.--In  an 
attempt to account for the differences observed after sensitization with HSA in 
different  adjuvants,  the  clearance  and  distribution  of  radioactive  HSA  was 
studied.  Guinea pigs were immunized with  100/zg 1~5I HSA in IFA, CFA,  or 
CFA  1:10,  and various organs were sampled from groups of five animals  at 
intervals up to 6 wk. The results of this study are summarized in Fig. 4 and in 
Table III. 
Antigen was cleared from the footpads exponentially and  at similar rates, 
regardless  of  the  adjuvant  employed. Approximately one-third  of  the  depot 
was exhausted at 1 day, one-half at 4 days, and two-thirds at 1 wk. At 6 wk all 
groups  retained  about  10%  of injected  antigen  in  their  footpads.  Similarity 208  HETEROGENEITY  OF  THE  CELLULAR  IMMUNE  RESPONSE.  II 
between  groups  at  all  intervals  was  remarkable  considering  the  swelling  and 
gross  ulceration  of  footpads  produced  by  the  adjuvants  containing  tubercle 
bacilli. 
A  sharp peak of activity appeared  in the plasma,  spleen,  thymus, and femur 
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Fro. 3.  Stimulation of thymidine incorporation of draining lymph node cells cultured with 
different concentrations of HSA 1 wk after sensitization with 100 #g HSA in IFA (O--•). 
IFA-tolerant  group  (O---•)  received  an additional  suppressing  injection of 5  mg HSA 
at  the  time  of  sensitization.  Closed  circles  designate  statistically  significant  stimulation 
(P <  0.05). 
TABLE  II 
Inhibition of Maerophage Migration in Delayed Hypersensitivity and Cutaneous 
Basophil Hypersensitivity 
Cytotoxlc index*  Immunization of  Time after 
peritoneal exudate  immunization  HSA concentration in culture (~g/ml) 
donor  10  100  1000 
(wk) 
Not immunized  --  0.99  4-  .08  1.08  4-  .06  1.31  4-  .14 
100/~g HSA-IFA  1  1.11  4-  . 10  1.05  4-  . 12  1.34  -4-  .13 
100#g HSA-CFA  1.18  4-  .08  1.10  4-  .07  0.88  4-  .07 
100#g HSA-IFA  3  0.98  4-  .04  1.02  4-  .08  1.02  4-  .08 
100#g HSA-CFA  0.50  4-  .06:~  0.37  4-  .06~  0.30  4-  .04~ 
* Mean cytotoxic index 4-  SE. Each number represents the average value obtained from 
octuplicate cultures prepared from four to six animals. 
:~ Statistically significant inhibition as compared with controls (P <  0.01). R.  C.  BAST, JR.,  B.  A.  SIN[PSON, AND tI.  F.  DVORAK  209 
1  day  after  sensitization, and  declined rapidly over  the  next  week  (Fig. 4). 
At 1  day,  animals sensitized with  antigen  in  IFA had  ten  times  the plasma 
concentration and five times the tissue levels of animals immunized with CFA. 
Sensitization with CFA l:10 led to an intermediate accumulation. 
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FIG. 4.  Distribution of human albumin in various tissues with time after sensitization  in 
the four footpads with 100 #g 1~5I HSA in IFA (O--O),  CFA ([-1.. "D), or CFA 1:10 
(A---A).  Data is expressed as nanograms  of HSA in the four footpads, pooled draining 
lymph nodes, 1 ml of plasma, one femur, entire spleen, and entire thymus. Each point repre- 
sents the average value obtained from five separate animals. 
The concentration of antigen in draining lymph nodes was of particular inter- 
est. Antigen continued to accumulate during the 1st wk, and here again a  sig- 
nificantly higher  antigen  concentration  was  found  after  IFA  immunization. 
Differences in antigen concentration were most dramatic when specific activities 
(total HSA/node weight) were compared, since adjuvants containing tubercle 
bacilli produced  significantly larger  lymph  nodes  containing  more  lymphoid 210  HETEROGENEITY  O~'  THE  CELLULAR  IMI~gUNE RESPONSE.  II 
cells (Table III). Thus, at 1 wk there was a 6-fold increase and at 3 and 6 wk a 
10-fold increase in the specific activities of HSA in lymph nodes draining an 
IFA depot as compared with nodes draining antigen in  CFA.  Similar values 
were obtained when  specific activity was  calculated on  the basis  of antigen 
per million recoverable draining lymph node cells (a 3-fold difference at  1 wk 
and a 13-fold difference at 6 wk)  (Table III). 
Total antigen retained within draining lymph nodes fell 3-4-fold between 1 
and 3 wk in animals sensitized with antigen in CFA or CFA 1 : 10; disappearance 
of antigen after IFA sensitization was considerably slower. 
TABLE  III 
Concentration of HSA in Draining Lymph Nodes at Various Intervals after Sensitization 
with 100 #g of Trace-Labded Antigen in CFA, CFA  1 : 10, and IFA. 
Specific activity  Specific activity 
Time after  Adjuvant  Total HSA  Node  weight*  ng HSA  Total cells  ng HSA X 106 
sensitization  (X I06):~ 
Node weight  Total cells 
(wk) 
1 
(*g)  (g) 
IFA  1298  0.4999  2611  270  4.8 
CFA 1:10  1022  0.8733  1490  388  2.6 
CFA  781  i. 7924  446  494  1.6 
IFA  960  0.8443  1141 
CFA 1 : 10  243  1.3072  184 
CFA  273  2.6305  106 
IFA  949  0.9293  1077  217  4.4 
CFA 1 : 10  180  1.4461  125  452  0.4 
CFA  179  1.9273  95  516  0.35 
* Wet weight. 
:~ Total cells recovered from all draining lymph nodes. 
DISCUSSION 
Our data indicate that the type of cellular immunity evoked in an animal-- 
its duration, evolution, and particularly the pattern of lymphocyte response in 
culture--is greatly affected by the concentration of tubercle bacilli provided in 
the sensitizing emulsion of Freund's adjuvant. Stimulation of lymph node cells 
from animals  receiving HSA in IFA occurred only at an early interval after 
sensitization, at a  time when cutaneous basophil hypersensitivity was readily 
elicited in the intact animal. The entire cellular response, in culture or in vivo, 
was transient and could not be detected 6 wk after sensitization. By contrast, 
sensitization with the same dose of HSA in CFA led to a persistent and evolving 
cellular response similar to that described in  the preceding paper  (13).  1 wk 
after  sensitization  significant  lymphocyte  stimulation  was  demonstrated 
only at a single high antigen concentration, but by 6 wk stimulation was ob- 
served over the entire 6 log10 range of antigen concentration tested. The ma×i- 
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parable to that recorded at 1 wk in the IFA group. However, the absolute level 
of thymidine incorporation was two to three times higher in the CFA group at 
this later interval, and there were approximately twice as many lymphoid cells 
in the enlarged nodes draining the site of a CFA injection. At both 1 and 6 wk 
animals sensitized with a reduced amount of tubercle bacilli (CFA 1:10) gave 
an in vitro response intermediate between that inSuced by IFA and CFA im- 
munization. 
We were not able to demonstrate significant inhibition of macrophage migra- 
tion in peritoneal exudates following immunization with HSA in IFA, contrary 
to earlier reports by Carpenter and Brandriss (15)  and by Gerety et al. (16). 
The success  of these groups may reflect the use of the more sensitive explant 
technique (15) or the different antigens studied. In any case, it is clear from the 
literature and from our data that much larger amounts of migration-inhibi- 
tory factor (MIF)  are produced following sensitization with CFA than with 
IFA and that MIF production is associated  with maturity of the cellular immune 
response (15-17). In our hands, nearly maximal inhibition was obtained with 
10 #g/ml of antigen, and others have reported inhibition with different anti- 
gens at concentrations several log10 dilutions lower (17) ; this is consistent with 
the possibility that lymphocytes reacting  at  low  antigen  concentration  are 
responsible for MIF production. 
In the preceding paper (13) the appearance of lymphocytes reacting at low 
antigen concentration in vitro was associated with a  progressive increase in 
the degree of induration of delayed reactions. Reactivity athigh antigen concen- 
tration was associated with nonindurated CBH reactions in animals recovering 
from tolerance. With further recovery, suppressed animals developed indurated 
skin tests and exhibited lymphocyte reactivity at lower antigen concentration 
in culture. A similar correlation was observed in the present study. Sensitiza- 
tion with 100/~g HSA in IFA permitted stimulation with no less than 10/~g 
HSA/ml, while cells from animals sensitized with the same amount of HSA in 
CFA reacted with as little as 0.1 ~g/ml. These data,  then, associate the in- 
durated  mononuclear  response  typical  of  mature  delayed  reactions  with 
the presence of lymphocytes capable of proliferation at low antigen concentra- 
tions.  Conversely,  CBH  reactions  were  associated  with  the  appearance  of 
lymphocytes reacting only at high antigen concentration. Appreciation of this 
difference in lymphocyte reactivity provides at least one explanation for the 
difficulty encountered in the production of complete tolerance in animals sensi- 
tized with IFA or  CFA  1:10.  Immunization with either of these adjuvants 
favors the  early production of cells  reacting at high  antigen concentration, 
precisely those cells least susceptible to a  suppressing injection (13).  By con- 
trast, CFA elicits only a slight and transient proliferation of such cells, selecting 
a population reacting at lower antigen concentration in culture that could be 
more readily suppressed in vivo by intravenous antigen. 
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the differences observed in response to identical quantities of antigen incorpo- 
rated in different adjuvants.  Sensitization with IFA produced an early pulse 
of antigen release from the injection site,  considerably greater than that ob- 
served in animals sensitized with CFA (Fig. 4). Levels in blood and lymphoid 
tissues 24 hr after 100 #g HSA in IFA approximated those seen at a  similar 
interval after intravenous injection of 25-50/~g HSA in saline. Systemic dissemi- 
nation of this amount of antigen could account for the split tolerance produced 
in guinea pigs after "sensitization" with large quantities of antigen in IFA (18, 
19), and might also explain the lack of lymphocyte reactivity at very low anti- 
gen concentration observed in vitro in our present study after immunization 
with 100/~g HSA in IFA. 
Considerably more HSA accumulated in draining lymph nodes when tubercle 
bacilli were omitted from the sensitizing emulsion. Maximal concentrations were 
achieved at 1 wk when specific activities were 3-6-fold lower in the CFA sensi- 
tized animals, due both to the greater absolute amount of antigen in the IFA 
nodes and  to the greater enlargement of nodes produced by tubercle bacilli. 
It is tempting to conclude that the higher concentration of antigen accumulat- 
ing after IFA  sensitization  favors proliferation  of a  cell population  reactive 
at  high  HSA  concentration,  predicted  by  the  antigen-selection  theory  of 
Siskind and Benacerraf (20) and actually observed in vitro in our present study. 
At later intervals, differences in antigen concentration were even more strik- 
ing, with specific activities 11 to 13 times greater in the IFA group at 6 wk. A 
large part of this difference can be attributed to a 3-fold reduction in the abso- 
lute amount of antigen present in draining nodes stimulated with CFA.  Con- 
sidering  that  antigen  was  cleared  from footpads  at  a  similar  rate  with  all 
adjuvants employed and that the relative distribution of antigen among differ- 
ent organs did not change between 1 and 6 wk, it seems probable that animals 
sensitized with  CFA catabolized antigen at an  enhanced rate. Whatever the 
mechanism  involved,  the  steady decrease in  antigen  concentration observed 
in  the lymph nodes of CFA-stimulated  animals  would favor the selection of 
cells  reacting at progressively lower antigen  concentration in  vitro  (20),  an 
evolution which, in fact, occurs. Whether the continued presence of high con- 
centrations of antigen in  lymph nodes draining IFA depots is related to the 
early termination  of cellular immunity,  either  as  cause  or  effect,  cannot be 
decided at present. 
Conflicting reports have attempted to correlate antigen-specific stimulation 
of thymidine uptake in vitro either with delayed hypersensitivity (21-23)  or 
with  antibody production  (24-26).  In  the preceding paper  (13)  1)anphocyte 
stimulation was observed 1 wk after immunization with 10 ~g HSA in Freund's 
complete adjuvant when delayed cutaneous reactivity was well established in 
the  absence of detectable antibody. A  similar correlation was  observed at 4 
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trast,  antigen-induced lymphocyte stimulation has been reported in  the ab- 
sence of delayed hypersensitivity following the intravenous or intracutaneous 
administration of soluble or particulate antigens to guinea pigs  (25),  rabbits 
(24,  26),  and primates  (27).  However, Turk and Heather (28),  Dvorak et al. 
(10),  and Richerson  5 have produced Jones-Mote or cutaneous basophil hyper- 
sensitivity administering soluble antigens by these routes. The close correla- 
tion of lymphocyte stimulation with CBH reported here is of interest in that 
CBH is a cell-mediated reaction, passively transferred with lymph node cells, 
but not with serum. At the same time, CBH is not associated with indurated 
reactions in vivo or appreciable MIF production in vitro, and the delayed ery- 
thematous reactions of  CBH may have been ignored or discounted in some 
studies.  While  numerous  reports  have  described  lymphocyte stimulation in 
patients  with  reagenic  allergy who  do  not  develop  delayed  skin  reactions, 
Brostoff and Roitt (23) have recently shown that administration of antihista- 
mine with skin test antigen blocks the immediate response  and permits  the 
expression of a weakly indurated reaction that is delayed in onset. 
Taken  together,  these  observations  suggest  that  cellular  immunity,  like 
antibody formation, encompasses a  heterogeneous group of reactions,  one of 
which is classic delayed hypersensitivity. They further suggest that lymphocyte 
stimulation in animals or patients who do not exhibit classic delayed cutaneous 
reactivity may nonetheless reflect the presence of other forms of cellular im- 
munity, either overt or latent. Brostoff and Roitt (23) have also suggested that 
the blast cell produced in vitro and observed in vivo is a th)~mus-derived inter- 
mediate whose progeny mediate cellular sensitivity on the one hand and cooper- 
ate in antibody production on the other. This model is  appealing in that it 
would predict the association of lymphocyte stimulation, CBH, and delayed 
hypersensitivity here reported. However, proliferation of antibody-forming cells 
and  their  precursors  has  been  demonstrated (24)  and  it is  not  possible  to 
exclude their possible contribution to the thymidine uptake observed in these 
experiments. 
SUMMARY 
Antigen-mediated stimulation of thymidine incorporation was demonstrated 
in lymph node cells from guinea pigs immunized with  100 #g human serum 
albumin in either Freund's incomplete or Freund's complete adjuvant. Ani- 
mals receiving HSA in IFA exhibited both cutaneous basophil (Jones-Mote) 
hypersensitivity and lymphocyte stimulation at 1, but not at 6 wk after immuni- 
zation. Significant stimulation required ~  10/zg HSA/ml of culture. Sensiti- 
zation with HSA  in  CFA produced delayed hypersensitivity and permitted 
lymphocyte stimulation at both 1 and 6 wk. Stimulation was observed with as 
little as 0.1/~g HSA/ml at the later interval. 
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Administration of 5 mg HSA intravenously at the time of sensitization with 
100 #g HSA in IFA reduced but did not eliminate both CBH and lymphocyte 
stimulation at 1 wk. 
Antigen-specific inhibition of macrophage migration could be demonstrated 
with exudates from animals immunized with HSA in CFA, but not with HSA in 
IFA at 3 wk after sensitization. 
HSA was cleared from depots of CFA and IFA at similar rates, but signifi- 
cantly more antigen appeared in the plasma and subsequently in the draining 
lymph nodes following administration in IFA. Conversely, accumulated anti- 
gen disappeared more rapidly following CFA immunization. 
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